Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo

References

• Burke DS, Monath TP. Flaviviruses. Fourth ed.: Lippincott William & Wilkins; 2001. (Knipe DM, Howley PM, editors. Fields Virology).
   Google Scholar
• Attar N. ZIKA virus circulates in new regions. Nat Rev Microbiol. 2016 Feb;14(2):62.
   Google Scholar
• Li Z, Zhang J, Li H. Flavivirus NS2B/NS3 protease: structure, function, and inhibition. In: Gupta SP, editor. Viral proteases and their inhibitors. San Diego, CA: Elsevier Inc; 2017. p. 163–188.
   Google Scholar
• Calvet G, Aguiar RS, Melo AS, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis. 2016 Feb 17;16:653–660.
   PubMed Web of Science ®Google Scholar
• Chen LH, Hamer DH. Zika virus: Rapid Spread in the Western Hemisphere. Ann Intern Med. 2016 Feb 2; 164(9):613–615.
   Web of Science ®Google Scholar
• Korhonen EM, Huhtamo E, Smura T, et al. Zika virus infection in a traveller returning from the Maldives, June 2015. Euro Surveill. 2016 Jan 14;21(2). doi:10.2807/1560-7917.ES.2016.21.2.30107
   PubMedGoogle Scholar
• Chen LH. Zika virus infection in a Massachusetts Resident after Travel to Costa Rica: A Case Report. Ann Intern Med. 2016 Feb 10;164:574–576.
   PubMed Web of Science ®Google Scholar
• Bogoch II, Brady OJ, Kraemer MU, et al. Anticipating the international spread of Zika virus from Brazil. Lancet. 2016 Jan 23;387(10016):335–336.
   PubMed Web of Science ®Google Scholar
• Patino-Barbosa AM, Medina I, Gil-Restrepo AF, et al. Zika: another sexually transmitted infection? Sex Transm Infect. 2015 Aug;91(5):359.
   PubMed Web of Science ®Google Scholar
• Musso D, Roche C, Robin E, et al. Potential sexual transmission of Zika virus. Emerg Infect Dis. 2015 Feb;21(2):359–361.
   PubMed Web of Science ®Google Scholar
• Musso D, Nhan T, Robin E, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill. 2014;19(14):20761. doi:10.2807/1560-7917.es2014.19.14.20761
   Google Scholar
• Foy BD, Kobylinski KC, Chilson Foy JL, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis. 2011 May;17(5):880–882.
   PubMed Web of Science ®Google Scholar
• Thomas DL, Sharp TM, Torres J, et al. Local transmission of Zika virus - Puerto Rico, November 23, 2015-January 28, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(6):154–158.
   PubMed Web of Science ®Google Scholar
• Martines RB, Bhatnagar J, Keating MK, et al. Notes from the field: evidence of Zika virus infection in brain and placental Tissues from Two Congenitally infected newborns and Two fetal Losses - Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(6):159–160.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Morales AJ. Zika and microcephaly in Latin America: An emerging threat for pregnant travelers? Travel Med Infect Dis. 2016 Feb 3;14:5–6.
   PubMed Web of Science ®Google Scholar
• Heinz FX, Stiasny K. Flaviviruses and flavivirus vaccines [Review]. Vaccine. 2012 Jun 19;30(29):4301–4306.
   PubMed Web of Science ®Google Scholar
• Thomas SJ, Yoon IK. A review of dengvaxia(R): development to deployment. Hum Vaccin Immunother. 2019;15(10):2295–2314.
   PubMed Web of Science ®Google Scholar
• Aguiar M, Stollenwerk N, Halstead SB. The impact of the Newly Licensed Dengue vaccine in Endemic countries. PLoS Negl Trop Dis. 2016 Dec;10(12):e0005179. doi:10.1371/journal.pntd.0005179
   Web of Science ®Google Scholar
• Noble CG, Seh CC, Chao AT, et al. Ligand-bound structures of the dengue virus protease reveal the active conformation. J Virol. 2012 Jan;86(1):438–446.
   PubMed Web of Science ®Google Scholar
• Prusis P, Lapins M, Yahorava S, et al. Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases [Research Support, Non-U.S. gov't]. Bioorg Med Chem. 2008 Oct 15;16(20):9369–9377.
   PubMed Web of Science ®Google Scholar
• Chambers TJ, Grakoui A, Rice CM. Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J Virol. 1991;65(11):6042–6050.
   PubMed Web of Science ®Google Scholar
• Falgout B, Pethel M, Zhang YM, et al. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol. 1991;65(5):2467–2475.
   PubMed Web of Science ®Google Scholar
• Lescar J, Luo D, Xu T, et al. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res. 2008 Nov;80(2):94–101.
   PubMed Web of Science ®Google Scholar
• Li Z, Brecher M, Zhang J, et al. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res. 2017;27:1046–1064.
   PubMed Web of Science ®Google Scholar
• Brecher M, Li Z, Liu B, et al. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease. PLoS Pathog. 2017 May 25;13(5):e1006411. doi:10.1371/journal.ppat.1006411
   PubMed Web of Science ®Google Scholar
• Li Z, Sakamuru S, Huang R, et al. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease. Antiviral Res. 2018 Feb;150:217–225.
   PubMed Web of Science ®Google Scholar
• Chappell KJ, Stoermer MJ, Fairlie DP, et al. Mutagenesis of the West Nile virus NS2B cofactor domain reveals two regions essential for protease activity. J Gen Virol. 2008 Apr;89(Pt 4):1010–1014.
   PubMed Web of Science ®Google Scholar
• Niyomrattanakit P, Winoyanuwattikun P, Chanprapaph S, et al. Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation. J Virol. 2004 Dec;78(24):13708–13716.
   PubMed Web of Science ®Google Scholar
• Papin J, Floyd R, Dittmer D. Methylene blue photoinactivation abolishes West Nile virus infectivity in vivo. Antiviral Res. 2005;68(2):84–87.
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH image to ImageJ: 25 years of image analysis. Nat Methods. 2012 Jul;9(7):671–675.
   PubMed Web of Science ®Google Scholar
• Jones C, Patkar C, Kuhn R. Construction and applications of yellow fever virus replicons. Virology. 2005;331(2):247–259.
   PubMed Web of Science ®Google Scholar
• Mohr H, Knuver-Hopf J, Gravemann U, et al. West Nile virus in plasma is highly sensitive to methylene blue-light treatment. Transfusion. 2004 Jun;44(6):886–890.
   PubMed Web of Science ®Google Scholar
• Floyd RA, Schneider JE Jr., Dittmer DP. Methylene blue photoinactivation of RNA viruses. Antiviral Res. 2004 Mar;61(3):141–151.
   PubMed Web of Science ®Google Scholar
• Boonyasuppayakorn S, Reichert ED, Manzano M, et al. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity. Antiviral Res. 2014 Jun;106:125–134.
   PubMed Web of Science ®Google Scholar
• Tabata T, Petitt M, Puerta-Guardo H, et al. Zika virus Targets different primary human placental cells, Suggesting Two Routes for Vertical transmission. Cell Host Microbe. 2016 Aug 10;20(2):155–166.
   PubMed Web of Science ®Google Scholar
• Tang H, Hammack C, Ogden SC, et al. Zika virus Infects human cortical neural progenitors and Attenuates their growth. Cell Stem Cell. 2016 May 5;18(5):587–590.
   PubMed Web of Science ®Google Scholar
• Zhang F, Hammack C, Ogden SC, et al. Molecular signatures associated with ZIKV exposure in human cortical neural progenitors. Nucleic Acids Res. 2016 Aug 31;44:8610–8620.
   PubMed Web of Science ®Google Scholar
• Qian X, Nguyen HN, Song MM, et al. Brain-Region-Specific organoids using mini-bioreactors for Modeling ZIKV exposure. Cell. 2016 May 19;165(5):1238–1254.
   PubMed Web of Science ®Google Scholar
• Garcez PP, Loiola EC, Madeiro da Costa R, et al. Zika virus impairs growth in human neurospheres and brain organoids. Science. 2016 May 13;352(6287):816–818.
   PubMed Web of Science ®Google Scholar
• Chambers SM, Fasano CA, Papapetrou EP, et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009 Mar;27(3):275–280.
   PubMed Web of Science ®Google Scholar
• Schwarz MC, Sourisseau M, Espino MM, et al. Rescue of the 1947 Zika virus Prototype strain with a Cytomegalovirus promoter-driven cDNA clone. mSphere. 2016 Sep-Oct;1(5). doi:10.1128/mSphere.00246-16
   Web of Science ®Google Scholar
• Qian X, Nguyen HN, Jacob F, et al. Using brain organoids to understand Zika virus-induced microcephaly. Development. 2017 Mar 15;144(6):952–957.
   PubMed Web of Science ®Google Scholar
• Xu YP, Qiu Y, Zhang B, et al. Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids. Cell Res. 2019 Apr;29(4):265–273.
   PubMed Web of Science ®Google Scholar
• Li C, Deng YQ, Wang S, et al. 25-Hydroxycholesterol protects host against Zika virus infection and Its associated microcephaly in a mouse model. Immunity. 2017 Mar 21;46(3):446–456.
   PubMed Web of Science ®Google Scholar
• Yoon S-J, Elahi LS, Pașca AM, et al. Reliability of human cortical organoid generation. Nat Methods. 2019;16(1):75–78.
   PubMed Web of Science ®Google Scholar
• Rossi SL, Tesh RB, Azar SR, et al. Characterization of a novel Murine model to study Zika virus. Am J Trop Med Hyg. 2016 Jun 1;94(6):1362–1369.
   PubMed Web of Science ®Google Scholar
• Lessler J, Chaisson LH, Kucirka LM, et al. Assessing the global threat from Zika virus. Science. 2016 Aug 12;353(6300). aaf8160. doi:10.1126/science.aaf8160
   Web of Science ®Google Scholar
• Lu G, Nagbanshi M, Goldau N, et al. Efficacy and safety of methylene blue in the treatment of malaria: a systematic review. BMC Med. 2018 Apr 25;16(1):59.
   PubMed Web of Science ®Google Scholar
• Walter-Sack I, Rengelshausen J, Oberwittler H, et al. High absolute bioavailability of methylene blue given as an aqueous oral formulation. Eur J Clin Pharmacol. 2009 Feb;65(2):179–189.
   PubMed Web of Science ®Google Scholar
• DiSanto AR, Wagner JG. Pharmacokinetics of highly ionized drugs. II. methylene blue–absorption, metabolism, and excretion in man and dog after oral administration. J Pharm Sci. 1972 Jul;61(7):1086–1090.
   PubMed Web of Science ®Google Scholar
• Peter C, Hongwan D, Kupfer A, et al. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol. 2000 Jun;56(3):247–250.
   PubMed Web of Science ®Google Scholar
• Schinazi RF, Floyd RA. inventors; Oklahoma Medical Research Foundation, assignee. ANTIVIRAL THERAPY USING THIAZINE AND XANTHENE DYES, International patent WO 90/13296 1990.
   Google Scholar
• Wood C, Habib N. inventors; BIOENVISION, INC, assignee. METHYLENE BLUE THERAPY OF VIRAL DISEASE, US patent US 2006/0264423 A1. USA2006.
   Google Scholar
• Guttmann P, Ehrlich P. Über die wirkung des methylenblau bei malaria. Berliner Klin Wochenschr. 1891;28:935–956.
   Google Scholar
• Wood HC. The use of methylene blue in malarial fevers. Proc Phila Co Med Soc. 1904;25:281–286.
   Google Scholar
• Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016 Mar;7(2):27–31.
   PubMedGoogle Scholar
• Lang Y, Li Z, Li H. Analysis of protein-protein interactions by split luciferase complementation assay. Curr Protoc Toxicol. 2019 Dec;82(1):e90.
   PubMedGoogle Scholar
• Ciota AT, Bialosuknia SM, Ehrbar DJ, et al. Vertical transmission of Zika virus by Aedes aegypti and Ae. albopictus Mosquitoes. Emerg Infect Dis. 2017 May;23(5):880–882.
   PubMed Web of Science ®Google Scholar
• Fulton BO, Sachs D, Schwarz MC, et al. Transposon Mutagenesis of the Zika virus genome Highlights regions Essential for RNA replication and Restricted for Immune Evasion. J Virol. 2017 Aug 1;91(15). doi:10.1128/JVI.00698-17
   PubMed Web of Science ®Google Scholar